78
Baylor Scott & White Heart and Vascular Hospital | Clinical Trials and Research
LOW-RISK BICUSPID VALVE TRIAL - Transcatheter aortic valve replacement ( TAVR ) with Medtronic Surgical Aortic Valve Replacement ( SAVR ). The study ’ s objective is to evaluate the procedural safety and efficacy of the Medtronic TAVR system in patients with bicuspid aortic anatomy and severe aortic stenosis at low risk for SAVR . Principal investigator : Ravi Vallabhan , MD .
LOQI IMPELLA REGISTRY - Long-term Outcome and Quality Indicator Impella Registry . Principal investigator : Cesar Guerrero-Miranda , MD .
Lp ( a ) ANALYSIS – Lipoprotein ( A ) bio-repository analytic study . Principal investigator : Subhash Banerjee , MD .
LSDR – The Rare Disease Registry program ( including Gaucher , Fabry , MPS I , and Pompe diseases ) is a multi-center , international , longitudinal , observational , and voluntary program that tracks the natural history and treatment outcomes of patients with these rare diseases , both treated and not treated . Principal investigator : Robert Gottlieb , MD , PhD .
LVAD SEXUAL QOL – How does living with an LVAD affect a couple ’ s sexual quality of life ? Principal investigator : Amit Alam , MD .
MEDTRONIC TAVR IN LOW RISK PATIENTS / LOW RISK CAS – A study evaluating transcatheter aortic valve replacement ( TAVR ) in patients with the Medtronic TAVR Replacement System in patients at low risk for surgical aortic valve replacement ( SAVR ). Principal investigator : Robert Stoler , MD .
MYLEUKOMAP – MyLeukoMAP genomic survival prediction assay pivotal clinical study . Principal investigator : Shelley Hall , MD .
OAKTREE - A Phase 3 randomized , double-blind placebo-controlled study to evaluate the efficacy and safety of GS-5245 for the treatment of COVID-19 in non-hospitalized participants . Principal investigator : Robert Gottlieb , MD , PhD .
ODYSSEY - A randomized , double-blind , placebocontrolled clinical study to evaluate mavacamten in adults with symptomatic non-obstructive hypertrophic cardiomyopathy . Principal investigator : Robert Gottlieb , MD , PhD .
OHP - I - OCS heart perfusion post-approval registry protocol . Principal investigator : Dan Meyer , MD .
OHP - II - Sponsor-initiated OCS heart perfusion ( OHP II ) registry . Principal investigator : Dan Meyer , MD .
PACCS - The pulmonary artery catheter in cardiogenic shock ( PACCS ) trial . Principal investigator : Cesar Guerrero-Miranda , MD .
PGD NATIONAL REGISTRY - Primary Graft Dysfunction International Consortium . Principal investigator : Shelley Hall , MD .
PHARMACOGENOMICS HTX - Pharmacogenomic associations with tacrolimus intrapatient variability and patient outcomes following heart transplantation . Principal investigator : Katarina Wells , MD .
POSEIDON - A study for the prevelence of inflammation in ASCVD populations . Principal investigator : Robert Gottlieb , MD , PhD .
PROTECT REGISTRY - PROSPERA TEST EVALUATION IN CARDIAC TRANSPLANT - The PROTECT registry is an observational longitudinal , multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care , who are enrolled within 60 days of heart transplantation . Principal investigator : Shelley Hall , MD .
RADPAD - The objective of this study is to determine if the novel use of a commercially-available radiation protection pad will significantly reduce the radiation exposure to the operating surgeon during fluoroscopic-imaging guided procedures . Principal investigator : Gregory Pearl , MD .
REBALANCE REGISTRY - Real-world experience - Barostim™ advancing the level of clinical evidence . Principal investigator : Amarinder Bindra , MD .
RECOVERY REGISTRY - Long-term outcomes after LVAD explantation for cardiac recovery . Principal investigator : Cesar Guerreo-Miranda , MD .
REDUCE LAP-HF - The study evaluates the Corvia Medical , Inc . IASD ® System II to reduce elevated left atrial pressure in patients with heart failure . The Corvia Medical InterAtrial Shunt Device ( IASD ® ) System II is indicated for the improvement in quality of life and reduction of heart failure related symptoms and events in patients with heart failure with preserved ( HFpEF ) or mid-range ejection fraction ( HFmrEF ) with elevated left atrial pressures , who remain symptomatic despite standard GDMT . Principal investigator : Cesar Guerrero-Miranda , MD .
reST STUDY - Prospective non-randomized post market study collecting clinical data on safety and effectiveness of the REM . Principal investigator : Parag Kale , MD .